LLBO Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
LLBO FAQ
What was Lifeline Biotechnologies Inc’s price range in the past 12 months?
Currently, no data Available
What is Lifeline Biotechnologies Inc’s market cap?
Lifeline Biotechnologies Inc’s market cap is $2.17M.
When is Lifeline Biotechnologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lifeline Biotechnologies Inc’s earnings last quarter?
Currently, no data Available
Is Lifeline Biotechnologies Inc overvalued?
According to Wall Street analysts Lifeline Biotechnologies Inc’s price is currently Overvalued.
Does Lifeline Biotechnologies Inc pay dividends?
Lifeline Biotechnologies Inc does not currently pay dividends.
What is Lifeline Biotechnologies Inc’s EPS estimate?
Lifeline Biotechnologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lifeline Biotechnologies Inc have?
Lifeline Biotechnologies Inc has 4,348,921,000 shares outstanding.
What happened to Lifeline Biotechnologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lifeline Biotechnologies Inc?
Currently, no hedge funds are holding shares in LLBO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lifeline Biotechnologies Inc
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. was incorporated in 1981 and is headquartered in Reno, Nevada.
Bio Green Med Solution
―
Biodexa Pharmaceuticals
―
Aethlon Medical
―
―
DIH Holdings US, Inc Class A
―